KLC
EW icon

Knowledge Leaders Capital’s Edwards Lifesciences EW Stock Holding History

Knowledge Leaders Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,082
Closed -$363K – 114
2022
Q1 		$363K Sell
3,082
-19
-0.6% -$2.13K 0.26% 106
2021
Q4 		$402K Buy
3,101
+241
+8% +$28.1K 0.29% 109
2021
Q3 		$324K Buy
2,860
+27
+1% +$3.08K 0.26% 105
2021
Q2 		$293K Buy
2,833
+112
+4% +$10.6K 0.2% 126
2021
Q1 		$228K Hold
2,721
– – 0.18% 109
2020
Q4 		$248K Buy
2,721
+3
+0.1% +$249 0.22% 104
2020
Q3 		$217K Buy
+2,718
New +$212K 0.21% 109

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Knowledge Leaders Capital's EW Position: Q2 2022 in Review

Knowledge Leaders Capital sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 3,082 shares — an estimated $363K sold.

Knowledge Leaders Capital first reported a position in EW in Q3 2020 and held it in 7 quarters. The position peaked at $402K in Q4 2021. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • Knowledge Leaders Capital reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • Knowledge Leaders Capital sold 3,082 Edwards Lifesciences shares in Q2 2022, an estimated $363K.
  • Knowledge Leaders Capital first reported a position in Edwards Lifesciences in Q3 2020 and held it in 7 quarters.
  • Knowledge Leaders Capital's Edwards Lifesciences position peaked at $402K in Q4 2021.
  • 1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Knowledge Leaders Capital's 13F filing for Q2 2022, filed 3 Aug 2022.